Pall Unveils Expanded Biopharmaceutical Manufacturing Product Line at INTERPHEX 2014
Pall Corporation, a global leader in high-tech filtration, separation and purification, is unveiling its expanded line of upstream and downstream capabilities including new single-use technologies for biopharmaceutical manufacturing at INTERPHEX 2014, booths 3021 and 3341. The show runs from 18–20 March at the Jacob K. Javits Center in New York, NY.
With the recent acquisitions of the LifeSciences business of ATMI, Medistad Holding BV and SoloHill Engineering Inc., Pall strengthened its upstream capabilities and already-established portfolio of single-use technologies. The company can now offer customers multiple solutions for their single-use applications. At INTERPHEX, the company’s extended suite of products is on display for the first time.
Following are new innovations Pall will be introducing at INTERPHEX:
• The AllegroTM STR 200 Single-use Bioreactor System is used for production-scale applications and is currently available in working volumes up to 200 L. The single-use stirred tank bioreactor features excellent mixing and mass transfer characteristics for upflow or downflow operations with minimum shear.
• The next generation of connector technology comes in the form of the Kleenpak II Sterile Connector, which offers a robust solution for large-scale, high-volume sterile fluid transfer. Available in 3Ž4 and 1” fittings, this connector enables secure, permanent connections for single-use or hybrid systems over 100 L in volume.
• Among the innovations from Pall’s acquisitions being introduced is an expanded range of cubical and round single-use tanks for biopharmaceutical and pharmaceutical mixing applications. There are 64 tanks designed for use, from bench to commercial scale, featuring standard options including state-of-the-art, ASME-certified insulated jackets and load cells with displays. All of the tanks in the range are made from standard materials, with consistent finishes and fully sealed frames.
• The off-the-shelf LevPak system, part of the Integrity product line that uses TK8 film, is the only product on the market that enables mixing, storage, shipping, remixing and dispensing of final biopharmaceutical and vaccine products in a single unit. It replaces traditional shipping methods such as glass or plastic bottles, and removes the need for additional process steps once a customer receives product, as it is ready to be mixed in situ.
Other Pall products being displayed at the show include
• The fully automated Allegro MVP single-use system is suitable for a wide range of upstream and downstream bioprocessing activities. It takes advantage of fully disposable flow paths and incorporates single-use sensors to monitor the process, maintain optimum conditions and get full batch records.
• Cadence Single-Use Inline Concentrator technology eliminates conventional recirculation loops with single-path tangential flow filtration that moves product through a proprietary design flow path in a pre-assembled module with all connections and couplings in place. The Cadence In-line Concentrator reduces pump and tube sizes, maximizes product recovery and exposes sensitive proteins to less shear. It can be used for production of monoclonal antibodies, fractionated antibodies, recombinant proteins and recombinant blood factors.
• The Resolute Auto Pak system allows fully automated column packing, unpacking or clean-in-place at the touch of a button. Users are able to pack all the slurry in the tank, eliminating sorbent carryover or wastage with a simplified setup that departs from traditional pump-pack methods and allows quicker turnaround of packing and unpacking operations.
• Also being spotlighted are Newform ultraclean pharmaceutical packaging and a range of single-use storage systems, mixers and bioreactors acquired from ATMI; microcarrier bead technology added from SoloHill; and specialized single-use systems engineering capabilities from Medistad.
At the show’s new Innovation Stages, Pall also will be well represented:
• Tuesday, 3/18 at 11:00 a.m. EST — BioProcess International Innovation Stage 1: Jerold Martin, Senior VP of Global Scientific Affairs, Pall Life Sciences, will participate in the roundtable "Harmonization of Single-Use Systems: Coordination of SUS Standards and Best Practice Efforts"
• Wednesday, 3/19 at 1:30 p.m. EST — BioPharm International Innovation Stage 2: Stéphanie Dubois, Cell Culture Lab Manager & Application Specialist, Pall Life Sciences, will present "Continuous Manufacturing for Biologic Drugs"
• Wednesday, 3/19 at 2:00 p.m. EST — BioProcess International Innovation Stage 1: Dr. Helene Pora, Vice President, Single-Use Systems, Pall Life Sciences, will present "The Application of Automation to Single-Use Systems: Efficacy and Improved Process Control”
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Women in Pharma: Minding the Gap at Pharmapack 2024
2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused... -
News Pharmapack Awards 2024 - Celebrating Packaging and Drug Delivery Innovation
The 2024 Pharmapack Innovation Awards ceremony celebrated the best in pharmaceutical packaging and drug delivery innovation at all levels. The awards were held on January 24, 2024 at the Paris Expo Porte de Versailles. -
News 2024 Pharma Industry Trends Outlook: Collaboration, Market Maturity, and Digital Futures
The annual CPHI Online 2024 Pharma Trends Outlook, in partnership with Arvato Systems, identifies 12 key industry trends shaping the life sciences industry in the coming year. -
News New Novo Nordisk AI hub for drug discovery to open in London, UK
Danish pharmaceutical giant Novo Nordisk will be opening an AI-based research facility in the heart of London to advance drug discovery operations. -
News BioNTech to begin mRNA vaccine manufacturing in Rwanda by 2025
German biotechnology company BioNTech has stated their intentions to begin production at their mRNA vaccine factory in Rwanda by 2025, which will mark the first foreign mRNA vaccine manufacturing site on the continent of Africa. -
News Women in Pharma: Looking back on 2023 and moving forward to 2024
In this monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News CPHI Barcelona 2023: Partnering for Success – Managing Outsourcing Relationships to Optimise Manufacturing Operations
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance